In case you have never attended an open house workshop at the NIH's Center for Scientific Review, in which people who participate in NIH peer review gather to discuss how the process is going and could improve, here's how it typically goes: Tuesday morning (December 18), about 80 stakeholders such as study section leaders in the Biomolecular group (about one-sixth of the entire CSR) gathered in a large auditorium of the Natcher Building on the NIH campus to consider two questions. 1. What will be the most important questions and/or enabling technologies you see forthcoming within the science of your discipline in the next 10 years? 2. Is the science of your discipline, in its present state, appropriately evaluated within the current study section alignment? Suggestions? (Note: Concurrent to the CSR review, the NIH is conducting an agency-wide review of peer review. You can linkurl:weigh in; on some of the...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?